| Literature DB >> 33511675 |
Bin Yu1, MengYuan Li1, HaiPeng Huang1, ShiQi Ma1, Ke Huang1, Zhen Zhong1, Shuo Yu1, LiYing Zhang1.
Abstract
WHAT IS KNOWN ANDEntities:
Keywords: acupuncture; an overview of systematic reviews; diabetic peripheral neuropathy
Mesh:
Year: 2021 PMID: 33511675 PMCID: PMC8247887 DOI: 10.1111/jcpt.13351
Source DB: PubMed Journal: J Clin Pharm Ther ISSN: 0269-4727 Impact factor: 2.512
PubMed search strategy
| #1 Search ((((acupuncture) OR electroacupunture) OR scalp acupuncture) OR warm acupuncture) OR auricular acupuncture |
| #2 Search (((((diabetes peripheral neuropathy) OR diabetic neuropathy) OR diabetic peripheral nerve disease) OR diabetic peripheral nerve lesion) OR diabetic peripheral neuropathies) OR diabetic peripheral neuropathy |
| #3 Search (((((systematic assessment) OR system evaluation) OR systematic evaluation) OR systematic review) OR systematical review) OR meta‐analysis |
| #4 #1AND#2AND#3 |
FIGURE 1Literature selection process
Table 1 basic characteristics of the included literature
| Included study | Country | Age | Study type | Number of documents | Therapy group | Control group | Methodology evaluation tools | Outcomes | Main conclusion |
|---|---|---|---|---|---|---|---|---|---|
| Sun 2019 | China | System assessment | 2/140 | Basic Therapy +Bloodletting | Basic treatment +Western medicine (methylcobalamin tablets, Micobo) | Jadad quality score | Clinical efficacy | The clinical efficacy of DPN combined with spinal bloodletting on the basis of conventional treatment is better than that of conventional treatment alone, which can better improve the quality of life and prognosis of patients. | |
| Zhu 2019 | China | Unlimited | System assessment | 7/580 | Basic acupuncture combined with acupuncture | Basic treatment | RCT bias risk assessment method |
Total effective rate for improvement of clinical symptoms and signs, Nerve conduction velocity (sensory and motor nerves) | Compared with basic therapy, acupuncture combined with basic therapy has a good effect in improving clinical effectiveness and peripheral nerve conduction velocity. |
| Yang 2014 | China | System assessment | 16/1141 | Acupuncture treatment (including milli‐needle and electroacupuncture) | Western medicine treatment (unlimited drug types) | Jadad scale | Total effective rate, peripheral nerve conduction velocity, plasma NO content | Acupuncture is effective in treating diabetic peripheral neuropathy. It improves peripheral nerve conduction velocity, increases plasma NO content, promotes local blood circulation, and improves nerve conduction. | |
| He 2019 | China | Unlimited | Meta‐analysis, trial sequential analysis | 16/1208 | Acupuncture(including fire acupuncture and bleeding, electro acupuncture +cupping with acupuncture) +control group | Basic treatment,basic treatment+mecobalamin point injection, basic treatment+mecobalamin tablets orally, basic treatment +mecobalamin intramuscular injection, basic treatment +oral Chinese medicine,basic treatment +oral vitamin and injection, basic treatment +epas Oral, basic treatment+Mudangranules | Improved Jadad scale, Cochrane5.1.0 biasriskassessment tool |
Clinical efficacy, signs, symptom score, nerve conduction velocity, Toronto clinical neuropathy score (TCSS) | Acupuncture has a good effect on diabetic peripheral neuropathy, which has a greater advantage than conventional western medicineꎮ |
| Ma 2019 | China | 50 ~ 65 years old | Meta‐analysis | 10/700 | Acupuncture, electric acupuncture, warm acupuncture, electronic moxibustion, Chinese medicine fumigation +acupuncture, low frequency pulse of acupuncture | Oral Micobo, intramuscular Micobo, oral mecobalamin, oral Neurotrophic drugs, oral+intramuscular vitamin B1, B12 | Jadad rating scale | Tibial nerve symptom improvement total effective rate, nerve measurement of conduction velocity (SNCV, MNCV), improvement of clinical symptoms, biochemical indicators | Acupuncture improves tibial nerve conduction velocity in DPN, which has certain advantages over conventional western medicine |
| Guo 2014 | China | Unlimited | Meta‐analysis | 5/347 | TCM acupuncture, TCM acupuncture +conventional drug treatment | Conventional medication |
Completely cured: Related symptoms disappear, Fasting blood glucose reaches normal levels; Improve: Relevant symptoms and laboratory tests have improved; Unhealed: No change in symptoms and laboratory tests | Acupuncture treatment is significantly more effective than conventional medications | |
| Xv 2016 | China | Unlimited | Meta‐analysis | 7/546 | Acupuncture combined with hypoglycemic and nutritional nerves conventionaltreatment | All are hypoglycemic, nutritional andother drugs Conventional treatment | Motor nerve conduction velocity sensory nerve conduction velocity | Acupuncture can broadly and significantly increase the speed of movement of limbs and sensory nerves in DPN patients, there by improving peripheral nerve function and alleviating persistent pain, numbness and sensory disturbances in the limbs. | |
| Liu 2014 | China | Unlimited | System assessment | 7/437 | Acupuncture, acupuncture, electro acupuncture, warm acupuncture | Drug therapy (methylcobalamin, sugar capsules, insulin, Gehuazhi), intramuscular injection of vitamin B1, vitamin B12 |
PEDro scale Cochrane bias risk assessment GRADE evidence quality assessment |
Efficient EMG | Compared with medicine, acupuncture has a good effect in terms of efficiency and improvement of clinical symptoms |
| liu 2016 | China | Unlimited | Meta‐analysis | 10/685 | Acupuncture, warm acupuncture, electro acupuncture, combined use of acupuncture, plum acupuncture, chest ankle acupuncture | Micobo, Nimodipine Tablets +VitaminB1,MicoboInjection VitaminB6Injection,VitaminB1+VitaminB12Injection, Nutritional Neuropharmaceuticals, Conventional Hypoglycemic Agents, Micobo Acupoint Injection, Mecobalamin |
Methodological quality evaluation cochrane 5.1.0 Risk assessment of bias |
Motor nerve conduction velocity (MNCV) Sensory nerve conduction velocity (SNCV) | Acupuncture treatment of peripheral neuropathy in type 2 diabetic patients improves peroneal nerves in both MNCV and SNCV, and it is superior to the control group without adverse reactions and high safety |
| Li 2015 | China | Unlimited | System assessment | 18/1158 | The treatment group used acupuncture(acupuncture, warm acupuncture,and acupuncture combined with moxibustion). Same group | Medication or blank control |
Cochrane Collaboration bias tool methodological bias risk assessment GRAD Eprofiler version 3.6 evidence quality assessment | Clinical efficacy: total effectiveness, peripheral nerve(including sensory and motor nerve) conduction speed, adverse reactions | Acupuncture treatment(common acupuncture treatment, warm acupuncture or acupuncture combined with moxibustion) was significantly better than the drug control group. Not only can improve the clinical effectiveness, but also significantly improve the peripheral nerve(including median nerve, common peroneal motor and sensory nerve)conduction velocity. No obvious adverse reactions |
| Cao 2011 | China | Unlimited | Meta‐analysis | 10/696 | Basic treatment +electroacupuncture + ear pressure, basic treatment +acupuncture +acupoint injection, acupuncture, basic treatment +acupuncture,acupuncture+acupoint injection,acupuncture, basic treatment +electroacupuncture, basic treatment+acupuncture | Basic treatment +mecobalamin, micobalamin, basic treatment +micobalamin, vitamin B1, B6, B12, basic treatment, basic treatment +nimoton + vitamin B1, B12 | Jadad quality score | Total effective rate of improvement of symptoms and signs, improvement of motor nerve conduction velocity, improvement of sensory nerve conduction velocity |
The current acupuncture treatment is not uniform, the diagnostic criteria and the curative effect criteria Criteria, follow‐up time, etc. are inconsistent, and the control groups in each study are different. At the same time, the existing data do notsuggestseriousadversereactionsandadverseevents, and there is no assessment of recurrence or quality of life. Insufficient evidence |
| Zhong 2019 | China | Unlimited | Meta‐analysis | 7/528 | Electronic moxibustion, acupuncture, electricacupuncture+electronic moxibustion,acupuncture +hyperbaric oxygen, electricacupuncture | Oral+intramuscular vitamin injection, intramuscular vitamin injection, oral MICOPRO tablets | Jadad quality score | Total effective rate for improvement of symptoms and signs, improvement of ulnarnerve motor nerve conduction velocity, sensory nerve conduction velocity |
Acupuncture can improve ulnar nerve conduction velocity, affirming acupuncture Clinical effect of moxibustion on DPN |
| Ma 2018 | China | Efficacy evaluation, meta‐analysis | 24/2277 | Combination of acupuncture and medicine on the basis of the control group | Conventional basic treatment | Jadad quality score | Total effective rate, cure rate, apparent efficiency, effective rate, inefficient | Compared with conventional basic treatment, the combination of acupuncture and medicine can significantly improve the total effective rate, cure rate, and significant efficiency of DPN patients, and reduce inefficiency. | |
| Jane Nash 2018 | Australia | ≥18 | Systematic review | (Ranged from 7 to 90) | Chinese medicine acupuncture, body acupuncture, ankle acupuncture | Vitamin B, Japanese acupuncture, fake acupuncture, VitaminB12, Japanese Matsumoto Kiko acupuncture, Parksham device |
Cochrane bias risk assessment tool NICMA N scale STRICTA project List of integrated reporting standards (CON SORT) | Symptomatic pain | Acupuncture improves symptoms and provides beneficial effects |
| Alexandra Dimitrova 2017 | USA | >18 | Systematic review, meta‐analysis | 4/322 | Electroacupuncture, Acupuncture, Electroacupuncture +, Acupuncture+Xuelian Injection,Acupuncture +Vitamin B12 | Intramuscular injection or intravenous injection of inositol, mecobalamin, vitamin B12 and other drugs | Scientific quality scale for complementary and alternative medicine surveys | Hemorheology, neurological examination, improvement of symptoms, NCV (MNCV), clinical signs score, symptoms score, improvement scale, neurological examination score | Acupuncture is effective for DPN |
| Wang 2018 | China | Systematic review | 14/1071 | Zusanli acupoint injection (the drug isunlimited and the same as the control group) | Intramuscular injection or blank control | Cochrane risk of bias (ROB) tool independent evaluation method | Adverse reactions, NCV, TCSS |
Zusanli acupoint injection can reduce pain score in patients with DPN And improve NCV | |
| Suzanne Amato Nesbit 2018 | USA | Systematic review | 1/45 | Cochrane risk of bias (ROB) tool independent evaluation method | Pain, quality of life | No conclusion | |||
| Chen 2013 | China | Systematic review | 25/1649 | Artificial acupuncture | False acupuncture, blank control, other non‐acupuncture treatments | CONSORT Statement, STRICTA 2010 | Improved symptoms, nerve conduction speed, adverse reactions | Artificial acupuncture has a certain effect on DPN |
Evaluation results of PRISMA statement
| Included studies | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun 2019 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 |
| Zhu 2019 | 1 | 0.5 | 1 | 0.5 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Yang 2014 | 1 |
0.5 5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| He 2019 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| Ma 2019 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| Guo 2014 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 0 | 0 |
| Xv 2016 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 0 | 0 |
| Liu 2014 | 1 | 0.5 | 1 | 0 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| liu 2016 | 1 |
0.5 55 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| Li 2014 | 1 | 0.5 | 1 | 0 | 0 | 0.5 | 1 | 1 | 1 | 0 | 0 |
| Cao 2011 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 0 | 0 |
| Zhong 2019 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| Ma 2018 | 1 | 0.5 | 1 | 0 | 0 | 0.5 | 1 | 0 | 1 | 1 | 0 |
| Jane Nash 2018 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 |
| Alexandra Dimitrova 2017 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 0 | 0 |
| Wang 2018 | 1 | 0.5 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 |
| Suzanne Amato Nesbit 2018 | 1 | 0.5 | 1 | 0.5 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Chen 2013 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 |
Item 1 title; item 2 structured abstract; item 3 theoretical basis; item 4 introduction purpose; item 5 scheme and registration; item 6 inclusion criteria; item 7 information source; item 8 retrieval; item 9 research selection; item 10 data extraction; Item 11 data item; item 12 single study bias; item 13 effect index; item 14 synthetic results method; item 15 inter‐study bias method; item 16 supplementary analysis method; item 17 research screening; item 18 study characteristics; Risks; item 20 individual research results; item 21 synthetic results; item 22 inter‐study bias results; item 23 supplementary analysis results; item 24 evidence summary; item 25 limitations; item 26 conclusions; item 27 funding.
Evaluation results of AMSTAR2 scale
| Included studies | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 | Item 12 | Item 13 | Item 14 | Item 15 | Item 16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sun 2019 | Y | N | N | PY | N | Y | N | N | N | N | N | N | N | Y | N | N |
|
Zhu 2019 | Y | N | N | PY | Y | Y | N | PY | Y | N | N | N | N | N | N | N |
|
Yang 2014 | Y | N | N | PY | Y | Y | N | PY | N | N | N | N | Y | N | Y | N |
|
He 2019 | Y | N | N | PY | Y | Y | N | N | Y | N | N | N | N | N | N | N |
|
Ma 2019 | Y | N | N | PY | Y | Y | N | N | N | N | N | N | N | Y | N | N |
|
Guo 2014 | Y | N | N | N | N | N | N | N | N | N | N | N | N | Y | N | N |
|
Xv 2016 | Y | N | N | PY | N | N | N | N | N | N | N | N | N | N | N | N |
|
Liu 2014 | Y | N | N | PY | Y | Y | N | N | Y | N | N | N | Y | N | N | N |
|
liu 2016 | N | N | N | PY | Y | Y | N | N | Y | N | N | Y | Y | Y | N | N |
|
Li 2014 | Y | N | N | PY | Y | Y | N | PY | Y | N | N | N | Y | N | N | N |
|
Cao 2011 | Y | N | N | PY | N | N | N | N | N | N | N | N | Y | N | Y | N |
|
Zhong 2019 | Y | N | N | PY | Y | Y | N | N | N | N | N | N | N | Y | N | N |
|
Ma 2018 | N | N | N | N | Y | Y | N | N | N | N | N | N | Y | N | N | N |
|
Jane Nash 2018 | Y | N | N | PY | N | Y | N | PY | Y | N | NO META | NO META | N | N | NO META | Y |
|
Alexandra Dimitrova 2017 | Y | N | N | PY | Y | Y | N | N | N | N | N | N | N | Y | N | Y |
|
Wang 2018 | Y | N | N | PY | Y | Y | N | N | Y | N | NO META | NO META | N | N | NO META | Y |
|
SuzanneAmato Nesbit 2018 | N | N | N | N | Y | Y | N | N | Y | N | NO META | NO META | N | N | NO META | Y |
|
Chen 2013 | Y | Y | N | PY | Y | Y | N | N | Y | N | N | N | Y | N | Y | N |
Key item; Y: Yes; N: No; PY: Partially yes; Item 1: do the study questions and inclusion criteria include PICO? Item 2: Are there pre‐published plans? Is there a clear bias between research and programmes? Item 3: Did the author explain the type of study design included? Item 4: Are comprehensive literature retrieval strategies used? Item 5: Were repeated studies screened? Item 6: Do you perform repeated data extraction? Item 7:Do you provide a list of excluded documents and explain why? Item 8: Are the included studies described in detail? Item 9: Were reasonable tools used to assess the risk of bias for each included study? Item 10: Are the funding sources included in the study reported? Item 11: If a meta‐analysis is performed, are the results statistically combined using appropriate methods? Item 12: If a meta‐analysis is performed, is the impact of bias risk explained in the results? Item 13: If a meta‐analysis was performed, is the discussion explaining the effect of the risk of bias? Item 14: Is there a reasonable explanation for heterogeneity in the discussion? Item 15: If quantitative analysis is performed, are publication biases sufficiently investigated and their possible impacts discussed? Item 16: Are there any potential sources of conflicts of interest reported?